US EditionPublished • loading... • Updated
Ranme President Asks Health for Public Funding for Dnatc Determination for Colorectal Cancer
Summary by diarioestrategia.cl
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The oncologist expert in colorectal cancer and president of the Real Academia Nacional de Medicina de España (RANME), Eduardo Díaz-Rubio, has asked the Ministry of Health to finance the testing of circulating tumor DNA (DNAtc) in all hospitals, as it allows predicting the prognosis and risk of recurrence in colorectal cancer.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
